WallStSmart

Concentrix Corporation (CNXC)vsWipro Limited ADR (WIT)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Wipro Limited ADR generates 9398% more annual revenue ($949.68B vs $10.00B). WIT leads profitability with a 13.9% profit margin vs -13.2%. CNXC appears more attractively valued with a PEG of 0.32. WIT earns a higher WallStSmart Score of 61/100 (C+).

CNXC

Buy

60

out of 100

Grade: C+

Growth: 7.3Profit: 4.0Value: 8.3Quality: 4.0
Piotroski: 4/9Altman Z: 0.92

WIT

Buy

61

out of 100

Grade: C+

Growth: 4.7Profit: 7.0Value: 5.7Quality: 7.5
Piotroski: 2/9Altman Z: 3.17
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CNXCUndervalued (+62.7%)

Margin of Safety

+62.7%

Fair Value

$93.25

Current Price

$26.56

$66.69 discount

UndervaluedFair: $93.25Overvalued

Intrinsic value data unavailable for WIT.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CNXC3 strengths · Avg: 9.3/10
PEG RatioValuation
0.3210/10

Growing faster than its price suggests

Price/BookValuation
0.6x10/10

Reasonable price relative to book value

EPS GrowthGrowth
36.1%8/10

Earnings expanding 36.1% YoY

WIT5 strengths · Avg: 9.0/10
Free Cash FlowQuality
$37.25B10/10

Generating 37.3B in free cash flow

Altman Z-ScoreHealth
3.1710/10

Safe zone — low bankruptcy risk

Debt/EquityHealth
0.279/10

Conservative balance sheet, low leverage

P/E RatioValuation
14.8x8/10

Attractively priced relative to earnings

Price/BookValuation
2.2x8/10

Reasonable price relative to book value

Areas to Watch

CNXC4 concerns · Avg: 3.0/10
Revenue GrowthGrowth
1.9%4/10

1.9% revenue growth

Market CapQuality
$1.49B3/10

Smaller company, higher risk/reward

Debt/EquityHealth
1.703/10

Elevated debt levels

Return on EquityProfitability
-47.6%2/10

ROE of -47.6% — below average capital efficiency

WIT3 concerns · Avg: 3.7/10
PEG RatioValuation
1.534/10

Expensive relative to growth rate

EPS GrowthGrowth
0.9%4/10

0.9% earnings growth

Piotroski F-ScoreQuality
2/93/10

Weak financial health signals

Comparative Analysis Report

WallStSmart Research

Bull Case : CNXC

The strongest argument for CNXC centers on PEG Ratio, Price/Book, EPS Growth. PEG of 0.32 suggests the stock is reasonably priced for its growth.

Bull Case : WIT

The strongest argument for WIT centers on Free Cash Flow, Altman Z-Score, Debt/Equity. Revenue growth of 10.6% demonstrates continued momentum.

Bear Case : CNXC

The primary concerns for CNXC are Revenue Growth, Market Cap, Debt/Equity. Debt-to-equity of 1.70 is elevated, increasing financial risk.

Bear Case : WIT

The primary concerns for WIT are PEG Ratio, EPS Growth, Piotroski F-Score.

Key Dynamics to Monitor

CNXC profiles as a turnaround stock while WIT is a value play — different risk/reward profiles.

CNXC carries more volatility with a beta of 0.45 — expect wider price swings.

WIT is growing revenue faster at 10.6% — sustainability is the question.

WIT generates stronger free cash flow (37.3B), providing more financial flexibility.

Bottom Line

WIT scores higher overall (61/100 vs 60/100) and 10.6% revenue growth. CNXC offers better value entry with a 62.7% margin of safety. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Concentrix Corporation

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Concentrix Corporation offers global technology customer experience solutions. The company is headquartered in Fremont, California.

Visit Website →

Wipro Limited ADR

TECHNOLOGY · INFORMATION TECHNOLOGY SERVICES · USA

Wipro Limited is a global information technology (IT), consulting and business process services company. The company is headquartered in Bengaluru, India.

Want to dig deeper into these stocks?